Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure

Current Cardiology Reviews

Volumn 4, Issue 3, 2008, Pages 219-222

  Ikeda, Uichi ^a   Kasai, Hiroki ^a   Izawa, Atsushi ^a   Koyama, Jun ^a   Yazaki, Yoshikazu ^a   Takahashi, Masafumi ^a   Higuchi, Makoto ^a   Koh, Chang Sung ^a   Yamamoto, Keiji ^b  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adrenoreceptor; Autoantibody; Cardiomyopathy; Heart failure; Immunoadsorption

Indexed keywords

EID: 54749116027     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340308785160534     Document Type: Review

References (39)

1. Taylor D, Edwards L, Boucek M, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report. J Heart Lung Transplant 2006; 25: 869-79.
2. Maisch B, Ristic AD, Hufnagel G, et al. Pathophysiology of viral myocarditis: the role of humoral immune response. Cardiovasc Pathol 2002; 11: 112-22.
3. Schulze K, Becker BF, Schauer R, et al. Antibodies to ADP-ATP carrier-an autoantigen in myocarditis and dilated cardiomyopathy - impair cardiac function. Circulation 1990; 81: 959-69.
4. Caforio AL, Grazzini M, Mann JM, et al. Identification of alpha-and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992; 85: 1734-42.
5. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against betaadrenoreceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989; 64: 97-103.
6. Magnusson Y, Wallukat G, Waastein F, et al. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoreceptor with positive chronotropic effect. Circulation 1994; 89: 2760-7.
7. Fu LX, Magnusson Y, Bergh CH, et al. Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993; 91: 1964-8.
8. Okazaki T. Honjo T. Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy. Trends Mol Med 2005; 11: 322-6.
9. Matsui S, Fu ML, Katsuda S, et al. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 1997; 29: 641-55.
10. Iwata M, Yoshikawa T, Baba A, et al. Autoimmunity against the second extracellular loop of beta1-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ Res 2001; 88: 578-86.
11. Jahns R, Boivin V, Hein L, et al. Direct evidence fro a beta1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004; 113: 1419-29.
12. Muller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997; 96: 542-9.
13. Jahns R, Boivin V, Siegmund C, et al. Autoantibodies activating human β1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999; 99: 649-54.
14. Christ T, Wettwer E, Dobrev D, et al. Autoantibodies against the beta1 adrenoreceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 2001; 33: 1515-25.
15. Wallukat G, Wollebgerger A. Effect of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic β adrenreceptor function in cultured neonatal rat heart myocytes. Biomed Biochim Acta 1987; 46: 634-9.
16. Magnusson Y, Marullo S, Hoyer S, et al. Mapping of a functional autoimmune epitope on the β1 adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1990; 86: 1658-63.
17. Matsui S, Fu M, Hayase M, et al. Transfer of rabbit autoimmune cardiomyopathy into severe combined immunodeficiency mice. J Cardiovasc Pharmacol 2003; 42: S99-S103.
18. Jane-wit D, Altuntas CZ, Johnson JM, et al. β1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation 2007; 116: 399-410.
19. Fukuda Y, Miyoshi S, Tanimoto K, et al. Autoimmunity against the second extracellular loop of beta1-adrenergic receptors induces early afterdepolarization and decreases in K-channel density in rabbits. J Am Coll Cardiol 2004; 43: 1090-100.
20. Iwata M, Yoshikawa T, Baba A, et al. Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2001; 37: 418-24.
21. Stork S, Boivin V, Horf R, et al. Stimulating autoantibodies directed against the cardiac beta1-adrenegic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 2006; 152: 697-704.
22. Aso S, Yazaki Y, Kasai H, et al. Association between anti-beta1-adrenergic receptor autoantibodies and myocardial sympathetic nervous activity assessed with iodine-123 metaiodobenzylguanidine scintigraphy in cases of chronic heart failure. Int J Cardiol 2008; Epub a head of print.
23. Wallukat G, Reinke P, Dorffel WV, et al. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption. Int J Cardiol 1996; 54:191-5.
24. Dorffel W, Felix S, Wallukat G, et al. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 1997; 95: 1994-7.
25. Felix SB, Staudt A, Dorffel W, et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three month results from a randomized study. J Am Coll Cardiol 2000; 35: 1590-8.
26. Muller J, Wallukat G, Dandel M, et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000; 101: 385-91.
27. Staudt A, Staudt Y, Hummel A, et al. Effects of Immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Ther Apher Dial 2006; 10: 42-8.
28. Wallukat G, Muller J, Hetzer R. Specific removal of β1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy (letter). N Eng J Med 2002; 347: 1806.
29. Staudt A, Schaper F, Stangl V, et al. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 2001; 103: 2681-6.
30. Staudt A, Bohm M, Knebel F, et al. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002; 106: 2448-53.
31. Staudt A, Dorr M, Staudt Y, et al. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption. Am Heart J 2005; 150: 729-736.
32. Cooper LT, Belohlavek M, Korinek J, et al. A pilot study to assess the use of protein A immunoadsorption for chronic dilated cardiomyopathy. J Clin Apheresis 2007; 22: 210-4.
33. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001; 103: 2254-9.
34. Schmaldienst S, Mullner M, Goldammer A, et al. Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases? Rheumatology (Oxford) 2001; 40: 513-21.
35. Mobini R, Staudt A, Felix SB, et al. Hemodynamic improvement and removal of autoantibodies against beta 1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 2003; 20: 345-50.
36. Felix SB, Staudt A, Landsberger M, et al. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 2002; 39: 646-52.
37. Schimke I, Muller JJ, Priem F, et al. Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol 2002; 38: 178-83.
38. Mann DL. Autoimmunity, immunoglobulin adsorption and dilated cardiomyopathy: has the time come for randomized clinical trials? J Am Coll Cardiol 2001; 38: 184-6.
39. Larsson L, Mobini R, Aukrust P, et al. Beneficial effect on cardiac function by intravenous immunoglobulin treatment in patients with dilated cardiomyopathy is not due to neutralization of anti-receptor autoantibody. Autoimmunity 2004; 37: 489-93.